Improvement of glucose tolerance in Zucker diabetic fatty rats by long-term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone.

MLA

Wargent, E., et al. “Improvement of Glucose Tolerance in Zucker Diabetic Fatty Rats by Long-Term Treatment with the Dipeptidyl Peptidase Inhibitor P32/98: Comparison with and Combination with Rosiglitazone.” Diabetes, Obesity & Metabolism, vol. 7, no. 2, Mar. 2005, pp. 170–81. EBSCOhost, https://doi.org/10.1111/j.1463-1326.2004.00383.x.

APA

Wargent, E., Stocker, C., Augstein, P., Heinke, P., Meyer, A., Hoffmann, T., Subramanian, A., Sennitt, M. V., Demuth, H.-U., Arch, J. R. S., & Cawthorne, M. A. (2005). Improvement of glucose tolerance in Zucker diabetic fatty rats by long-term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone. Diabetes, Obesity & Metabolism, 7(2), 170–181. https://doi.org/10.1111/j.1463-1326.2004.00383.x

Chicago

Wargent, E., C. Stocker, P. Augstein, P. Heinke, A. Meyer, T. Hoffmann, A. Subramanian, et al. 2005. “Improvement of Glucose Tolerance in Zucker Diabetic Fatty Rats by Long-Term Treatment with the Dipeptidyl Peptidase Inhibitor P32/98: Comparison with and Combination with Rosiglitazone.” Diabetes, Obesity & Metabolism 7 (2): 170–81. doi:10.1111/j.1463-1326.2004.00383.x.